Mindblown: a blog about philosophy.
-
Makeup Artist Turned Wellness Advocate Launches World’s First Tallow-Based Tinted Moisturizer
Ginger Lily Tallow was born from one woman’s search for healing. A professional makeup artist’s journey through chronic illness led to a groundbreaking skincare-meets-makeup innovation that is redefining clean, ingredient-conscious cosmetics. North Carolina, United States – In a beauty industry saturated with synthetic serums and chemical-laden foundations, one brand is returning to nature. Ginger Lily Tallow…
-
New Book The Dopamine Debt Explores Why Modern Life Makes It So Hard to Stay Focused
The Dopamine Debt The Dopamine Debt examines how constant digital stimulation quietly reshapes focus, motivation, and emotional well-being, while offering a practical path toward lasting awareness. Blending behavioural psychology with everyday experiences, Anshu Varma examines how constant digital stimulation shapes attention, motivation, and emotional well-being in the modern world. If you’ve ever asked yourself why…
-
Unbroken Soul by Madhulika Syal Offers a Powerful Story of Resilience, Healing, and Emotional Survival
UNBROKEN SOUL: A Phoenix Rising from Shadows into Eternal Love Unbroken Soul: A Phoenix Rising Through Shadows, Tears, and Eternal Love is a moving memoir about resilience, grief, healing, motherhood, and rediscovering love after life’s deepest betrayals. A deeply personal new memoir, Unbroken Soul: A Phoenix Rising Through Shadows, Tears, and Eternal Love by Madhulika…
-
Epilepsy Market Shows Strong Future Potential with Increasing Industry Investments by 2036 – DelveInsight | ES Therapeutics, PhytoTech Therapeutics, UCB Biopharma, SK Life Science, UCB Biopharma
The Key Epilepsy Companies in the market include – Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others. DelveInsight’s “Epilepsy Market Insights, Epidemiology, and Market Forecast-2036″ report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well…
-
Myotonic Dystrophy Market Expected to Experience Accelerated Growth and Market Evolution by 2036 – DelveInsight | Design Therapeutics, Enzerna, Juvena Therapeutics, Dyne Therapeutics, Avidity Bioscien
The Key Myotonic Dystrophy Companies in the market include – EditForce, Inc., Arrowhead Pharmaceuticals, Inc., Vertex Pharmaceuticals, Pepgen Corporation, Avidity Biosciences, Design Therapeutics, Enzerna, Juvena Therapeutics, Dyne Therapeutics, Avidity Biosciences, Harmony Biosciences, AMO Pharma, Lupin, AMO Pharma, Dyne Therapeutics, Entrada Therapeutics, and others. DelveInsight’s “Myotonic Dystrophy Market Insights, Epidemiology, and Market Forecast-2036″ report offers…
-
Judge James P Gray Presents Practical Solutions to Americas Challenges in A Voter’s Handbook How Citizens Can Make a Difference
Retired Judge James P. Gray brings decades of legal, public service, and civic experience to his latest work, A Voter’s Handbook: Effective Solutions to America’s Problems, a timely and thought-provoking collection of insights designed to encourage Americans to engage deeply with the issues facing the nation. Gray, who served in the Peace Corps in Costa…
-
Head and Neck Squamous Cell Carcinomas Market Unlocking New Revenue Opportunities and Strategic Expansion by 2034 – DelveInsight | Sidney Kimmel, Centre hospitalier de, Dana-Farber Cancer Institute
The Key Head and Neck Squamous Cell Carcinomas Companies in the market inlude – M.D. Anderson Cancer Center, Sidney Kimmel, Centre hospitalier de, Dana-Farber Cancer Institute, Inovio Pharmaceuticals, Hansoh BioMedical R&D Company, Gilead Sciences, Merck Sharp & Dohme LLC, Exelixis, Sichuan Baili Pharmaceutical Co., Ltd., AVEO Pharmaceuticals, Inc., Benitec Biopharma, Inc., BeiGene, ALX Oncology Inc.,…
-
Osteoarthritis Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Merck, Peptinov, LG Chem, Akan Bioscience, BioTissue, Eupraxia Pharma, OliPass
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Osteoarthritis pipeline constitutes 100+ key companies continuously working towards developing 110+ Osteoarthritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Osteoarthritis Pipeline Insight, 2026″ report by DelveInsight outlines comprehensive insights into the present clinical development…
-
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Potential by 2036 – DelveInsight | Teva Pharma, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharma, Reviva Pharma
The Key Schizophrenia Companies in the market include – Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others. DelveInsight’s report “Schizophrenia Market…
-
Barry BJ Spaulding Explores Faith Personal Responsibility and Life’s Greatest Questions in His Thought-Provoking Novel “Who’s to Blame”
Author Barry “BJ” Spaulding invites readers on a profound journey of faith, accountability, and personal transformation with the release of his compelling novel, Who’s to Blame. Through a thought-provoking exploration of hardship, belief, and the human experience, Spaulding presents a story that challenges readers to look beyond their circumstances and discover the strength found in…
Got any book recommendations?